About Lipoma-preferred partner
Lipoma-preferred partner (LPP) is a protein
from Homo sapiens identified by UniProt accession
Q93052, 612 residues long.
MolForge cross-references it against 0 known binders and
424 disease associations.
Target properties
| Protein name | Lipoma-preferred partner |
| UniProt accession | Q93052 |
| Gene | LPP |
| Organism | Homo sapiens |
| Length | 612 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (424)
Diseases linked to this target (Open Targets).
- acute myeloid leukemia · score 0.44
- skin carcinoma · score 0.43
- body height · score 0.41
- body mass index · score 0.39
- intraocular pressure measurement · score 0.38
- asthma · score 0.38
- celiac disease · score 0.38
- prostate adenocarcinoma · score 0.37
- pancreatic ductal adenocarcinoma · score 0.37
- pancreatic carcinoma · score 0.37
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q93052-F1 | alphafold | PREDICTED | 60.38 | — |
Amino-acid sequence (612 residues)
MSHPSWLPPK STGEPLGHVP ARMETTHSFG NPSISVSTQQ PPKKFAPVVA PKPKYNPYKQ PGGEGDFLPP PPPPLDDSSA LPSISGNFPP PPPLDEEAFK VQGNPGGKTL EERRSSLDAE IDSLTSILAD LECSSPYKPR PPQSSTGSTA SPPVSTPVTG HKRMVIPNQP PLTATKKSTL KPQPAPQAGP IPVAPIGTLK PQPQPVPASY TTASTSSRPT FNVQVKSAQP SPHYMAAPSS GQIYGSGPQG YNTQPVPVSG QCPPPSTRGG MDYAYIPPPG LQPEPGYGYA PNQGRYYEGY YAAGPGYGGR NDSDPTYGQQ GHPNTWKREP GYTPPGAGNQ NPPGMYPVTG PKKTYITDPV SAPCAPPLQP KGGHSGQLGP SSVAPSFRPE DELEHLTKKM LYDMENPPAD EYFGRCARCG ENVVGEGTGC TAMDQVFHVD CFTCIICNNK LRGQPFYAVE KKAYCEPCYI NTLEQCNVCS KPIMERILRA TGKAYHPHCF TCVMCHRSLD GIPFTVDAGG LIHCIEDFHK KFAPRCSVCK EPIMPAPGQE ETVRIVALDR DFHVHCYRCE DCGGLLSEGD NQGCYPLDGH ILCKTCNSAR IRVLTAKAST DL
Explore Lipoma-preferred partner with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets